Curatis AG is a Originators company based in Liestal (Basel-Landschaft) recorded by Swissmedic as the authorisation holder for 30 human medicines. That places it 56 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Liestal |
| Canton | Basel-Landschaft |
| Authorisation holder | Yes |
| Medicines | 30 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Curatis Holding AG |
| Activity | Not available |
| Website | curatis.com |
Medicines authorised in Switzerland
Curatis AG is recorded by Swissmedic as the authorisation holder for 30 human medicines. The table shows 30 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
30 of 30 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Actiq 200 Mikrogramm | 57002 | A+ | N02AB03 | 2005-06-16 |
| Aggrastat | 55738 | A | B01AC17 | 2001-03-19 |
| Ambiful 250 mg/5 ml | 67512 | B | L02BA03 | 2020-02-10 |
| Brinavess 500 mg | 61304 | B | - | 2011-03-16 |
| Coldistop | 38189 | D | R01AX02 | 1975-04-07 |
| Cuprior 150 mg | 67719 | B | A16AX12 | 2021-01-21 |
| Curapressin 1 mg/5 ml | 70030 | B | H01BA04 | 2025-12-23 |
| Cyanokit 5g | 60539 | A | V03AB33 | 2009-10-06 |
| DigiFab | 59301 | A | V03AB24 | 2010-01-08 |
| Effentora 100 mcg | 61669 | A+ | N02AB03 | 2011-06-29 |
| Effortil | 24199 | B | C01CA01 | 1958-09-18 |
| Elmiron 100 mg | 67306 | B | G04BX15 | 2020-09-24 |
| Fluoresceine 10 % Faure | 54604 | B | S01JA01 | 1999-08-10 |
| Fluorescéine 0 | 46996 | B | S01JA01 | 1987-10-23 |
| Foscavir | 52357 | A | J05AD01 | 1993-08-30 |
| Garamycin | 52918 | A | J01GB03 | 1996-10-10 |
| Mysoline | 17885 | B | N03AA03 | 1952-10-15 |
| PRILIGY | 60470 | B | G04BX14 | 2012-10-19 |
| Proleukin | 50581 | A | L03AC01 | 1995-09-12 |
| Propycil 50 | 56300 | B | H03BA02 | 2005-04-22 |
| Psychopax | 44941 | B | N05BA01 | 1984-05-28 |
| Pylori 13 | 54192 | B | V04CX | 2000-10-20 |
| Relistor | 58652 | B | A06AH01 | 2009-04-15 |
| Spedra 50 mg | 65275 | B | G04BE10 | 2016-01-22 |
| Succicaptal | 62303 | A | V03AB | 2012-05-09 |
| Tiberal 500 mg | 44231 | B | P01AB03 | 1982-03-11 |
| Tiberal 500 mg/3 mL | 43065 | B | P01AB03 | 1980-07-03 |
| Toxogonin | 31514 | B | V03AB13 | 1965-06-09 |
| Xenazine | 58375 | B | N07XX06 | 2008-12-18 |
| Zonegran 25 mg | 57629 | B | N03AX15 | 2006-10-19 |
Frequently asked questions
How many medicines does Curatis AG have authorised in Switzerland?
Curatis AG is recorded by Swissmedic as the authorisation holder for 30 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Curatis AG based?
The Swiss location recorded for Curatis AG is Liestal, Basel-Landschaft.
Is Curatis AG a Swissmedic authorisation holder?
Yes. Curatis AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.